BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33964868)

  • 1. Current diagnosis and treatment of acute pancreatitis in China: a real-world, multicenter study.
    Sun C; Li Z; Shi Z; Li G
    BMC Gastroenterol; 2021 May; 21(1):210. PubMed ID: 33964868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current usage status of somatostatin and its analogs and trypsin inhibitors: a real-world study of 34,654 Chinese adult patients with acute pancreatitis.
    Mao X; Yang Z
    Ann Palliat Med; 2021 Feb; 10(2):1325-1335. PubMed ID: 33040552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of somatostatin and its analogues in the treatment of acute pancreatitis: clinical retrospective study].
    Citone G; Perri S; Nardi M; Maira E; Lotti R; Gabbrielli F; Antonellis M; Orsini S
    G Chir; 2001 Apr; 22(4):139-49. PubMed ID: 11370223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin and octreotide on the treatment of acute pancreatitis - basic and clinical studies for three decades.
    Li J; Wang R; Tang C
    Curr Pharm Des; 2011; 17(16):1594-601. PubMed ID: 21548873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of organ failure in patients with predicted severe acute pancreatitis treated by somatostation, octreotide and cyclooxygenase-2 inhibitors.
    Huang ZY; Gong H; Tang CW; Wang MJ; Wang R
    Pancreatology; 2024 Feb; 24(1):24-31. PubMed ID: 38155082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of somatostatin and octreotide on experimental and human acute pancreatitis.
    Greenberg R; Haddad R; Kashtan H; Kaplan O
    J Lab Clin Med; 2000 Feb; 135(2):112-21. PubMed ID: 10695655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative treatment of acute pancreatitis: the use of somatostatin.
    Ladas SD; Raptis SA
    Hepatogastroenterology; 1992 Oct; 39(5):466-9. PubMed ID: 1360937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of octreotide pretreatment in experimental acute pancreatitis.
    Salem MZ; Cunha JE; Coelho AM; Sampietri SN; Machado MC; Penteado S; Abdo EE
    Pancreatology; 2003; 3(2):164-8. PubMed ID: 12748426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis.
    Büchler MW; Binder M; Friess H
    Gut; 1994; 35(3 Suppl):S15-9. PubMed ID: 7911442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin in the treatment of pancreatic diseases].
    Németh AM
    Orv Hetil; 2002 May; 143(19 Suppl):1099-108. PubMed ID: 12063869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of octreotide and somatostatin in acute and chronic pancreatitis.
    Uhl W; Anghelacopoulos SE; Friess H; Büchler MW
    Digestion; 1999; 60 Suppl 2():23-31. PubMed ID: 10207228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of somatostatin and octreotide in the management of acute pancreatitis.
    Büchler MW; Binder M; Friess H; Malfertheiner P
    Digestion; 1994; 55 Suppl 1():16-9. PubMed ID: 7907565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats.
    Paran H; Klausner J; Siegal A; Graff E; Freund U; Kaplan O
    J Surg Res; 1996 May; 62(2):201-6. PubMed ID: 8632640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of somatostatin and its analogues in pancreatic surgery and pancreatic disorders.
    Friess H; Büchler MW
    Digestion; 1996; 57 Suppl 1():97-102. PubMed ID: 8813484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomised, double blind, multicentre trial of octreotide in moderate to severe acute pancreatitis.
    Uhl W; Büchler MW; Malfertheiner P; Beger HG; Adler G; Gaus W
    Gut; 1999 Jul; 45(1):97-104. PubMed ID: 10369711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin and octreotide in acute pancreatitis: the never-ending story.
    Cavallini G; Frulloni L
    Dig Liver Dis; 2001 Mar; 33(2):192-201. PubMed ID: 11346150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis of somatostatin, octreotide and gabexate mesilate in the therapy of acute pancreatitis.
    Andriulli A; Leandro G; Clemente R; Festa V; Caruso N; Annese V; Lezzi G; Lichino E; Bruno F; Perri F
    Aliment Pharmacol Ther; 1998 Mar; 12(3):237-45. PubMed ID: 9570258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, controlled trial of octreotide in the management of patients with acute pancreatitis.
    McKay C; Baxter J; Imrie C
    Int J Pancreatol; 1997 Feb; 21(1):13-9. PubMed ID: 9127169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive hemorrhagic erosive gastritis associated with acute pancreatitis successfully treated with a somatostatin analog.
    Yabuki K; Maekawa T; Satoh K; Tamasaki Y; Maekawa H; Kudoh K; Aoki E
    J Gastroenterol; 2002; 37(9):737-41. PubMed ID: 12375148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.